tldrdailynews.com logo

FDA approves Moderna’s mRNA flu shot for adults 50+, signaling a new vaccine era

1 min read
Source: Ars Technica
FDA approves Moderna’s mRNA flu shot for adults 50+, signaling a new vaccine era
Photo: Ars Technica
TL;DR

FDA approval grants Moderna’s mRNA influenza shot, mFLUSIVA (mRNA-1010), for adults 50 and up, marking the first mRNA flu vaccine and following a unanimous June advisory panel vote citing strong efficacy and safety in about 44,000 people. The path to approval was politically tense due to anti-vaccine motivations within the Kennedy administration, and questions remain about ACIP recommendations, coverage, and near-term sales expectations, with Moderna aiming for the 2026–27 season.

Topics:top-newshealth#acip#fda-approval#flu-vaccine#health#moderna#mrna-vaccine
Share this article
  1. Moderna’s mRNA flu shot earns FDA approval after rollercoaster review  Ars Technica
  2. What to know about the first mRNA-based flu shot approved by the FDA  The Washington Post
  3. F.D.A. Approves Moderna’s mRNA Flu Vaccine  The New York Times
  4. A new flu vaccine geared to older people is coming soon  NPR
  5. One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was  STAT

Want the full story? Read the original reporting

Read on Ars Technica